Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States

There are currently hundreds of businesses across the United States offering direct-to-consumer stem cell treatments that have not been through regulatory approval by the Food and Drug Administration (FDA). Here, we provide a detailed characterization of nearly 170 stem cell businesses operating in...

Descripción completa

Detalles Bibliográficos
Autores principales: Frow, Emma K., Brafman, David A., Muldoon, Anna, Krum, Logan, Williams, Paige, Becker, Bryson, Nelson, John P., Pritchett, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700498/
https://www.ncbi.nlm.nih.gov/pubmed/31378670
http://dx.doi.org/10.1016/j.stemcr.2019.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700498/
https://www.ncbi.nlm.nih.gov/pubmed/31378670
http://dx.doi.org/10.1016/j.stemcr.2019.07.001

Ejemplares similares